Clinical Trial Update: Baricitinib in the Treatment of Intestinal Behçet's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating baricitinib for intestinal Behçet's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Behcet Syndrome, Intestinal Type | Phase 2 | Status: RECRUITING